Spain· ES:1221649001
LUNSUMIO 1 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing mosunetuzumab, registered in Spain by Roche Registration Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- mosunetuzumab
- Manufacturer
- Roche Registration Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mosunetuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLunsumio 1mg/1ml concentrate for solution for infusion vialsRoche Products Ltd
- United StatesLunsumioGenentech, Inc.
- FinlandLunsumioRoche Registration GmbH
- CzechiaLUNSUMIORoche Registration GmbH, Grenzach-Wyhlen
- IrelandLunsumio 1 mg concentrate for solution for infusionRoche Registration GmbH
- SwitzerlandLunsumio 1 mg/1 ml, Konzentrat zur Herstellung einer InfusionslösungRoche Pharma (Schweiz) AG
- PolandLunsumioRoche Registration GmbH
- SwedenLunsumio 1 mg Koncentrat till infusionsvätska, lösningRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lunsumio
- Liechtenstein · Lunsumio
- Norway · Lunsumio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae8617e8-1a6d-48ad-b601-e7abc0d3f3d0 GET /v1/drugs/ae8617e8-1a6d-48ad-b601-e7abc0d3f3d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1656657550000}",
"nregistro": "1221649001",
"substance": "mosunetuzumab"
}See everything about mosunetuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.